Pick 3 Contest 3

[rocketeer357]

CPXX was a good one to be sure.

There are a number of micro bios with pending catalysts in Q2 which could make big moves. They're all risky but could bust big moves with successful news.

The sweet thing about CPXX was that the risk of success in their phase 3 trial was mitigated by the fact that they were delivering an established treatment that hadn't seen an upgrade for decades rather than trying to bring a new compound to market.

Wish it was 1/3 of my real portfolio, but with a 12% position before the big run up, it has been a good week. (sold out at $8.60).

Years ago I rode 100k shares of CTGI from .04 to $2.37 without selling a share. That company is now bankrupt. Never again!